首页 › 基金 › BALANCE CAPITAL PARTNERS L.P. › DNA
BALANCE CAPITAL PARTNERS L.P. 对 DNA 的持仓历史
GINKGO BIOWORKS HOLDINGS INC · 医疗保健
BALANCE CAPITAL PARTNERS L.P. 在 Q2 2026 的 13F 申报中披露持有 DNA(GINKGO BIOWORKS HOLDINGS INC)199,009 股,市值约 US$2.0M,约占其申报组合的 1.42%,在其申报持仓中市值排名第 10 位。 BALANCE CAPITAL PARTNERS L.P. 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
BALANCE CAPITAL PARTNERS L.P. 对 DNA 的持仓演变
BALANCE CAPITAL PARTNERS L.P. 于 Q2 2026 首次披露 DNA 持仓:199,009 股(约 US$2.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 199.01K | $1.97M | 新进 |
关于 DNA 与 13F 数据
DNA(GINKGO BIOWORKS HOLDINGS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 DNA,申报仓位最大的包括:Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DNA 的基金
- Anchorage Capital Group, L.L.C. 1.75M 股 · $17.31M · Q2 2026
- FORBES J M & CO LLP 977.37K 股 · $12.54M · Q3 2026
- SB INVESTMENT ADVISERS (UK) LTD 610.73K 股 · $6.05M · Q2 2026
更多关于 BALANCE CAPITAL PARTNERS L.P.
常见问题
How long has BALANCE CAPITAL PARTNERS L.P. held DNA?
BALANCE CAPITAL PARTNERS L.P. has disclosed DNA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is BALANCE CAPITAL PARTNERS L.P.'s current position in DNA?
As of Q2 2026, BALANCE CAPITAL PARTNERS L.P. holds 199.01K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $1.97M, representing 1.42% of its reported portfolio and ranking #10.
Has BALANCE CAPITAL PARTNERS L.P. been buying or selling DNA?
In the latest 13F filing (Q2 2026), BALANCE CAPITAL PARTNERS L.P. newly opened its position in DNA.
Which other funds hold DNA?
Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.